Triple-negative breast cancer (TNBC) is one of the subtypes of breast cancer, which is named because of the negative expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2). This evidence concerns the gene PGR and triple-negative breast carcinoma.